60 likes | 64 Views
Growth Drivers<br>The increasing popularity of personalized medicine, drug revelation, and life science research, adoption of biomarkers-based detection, and demand for high-speed diagnostic are important factors that fuel the growth of the global lab-on-chip market.
E N D
About VynZ Research… • VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. • VynZ Research has one of the most qualified & experienced analysts, who are constantly tracking the markets and the technologies. The research team has years of proven experience and wide knowledge & understanding of the technology, application, business models, and regulators of the segments and the value chain involved. • A trusted & proven methodology that involves highest quality of primary research, secondary analysis collated & verified through various sources including cross checking with different industry experts. • Serving wide range of customers most of them from Fortune 2000 companies • With a dedicated 24x7 customer helpline our customers can reach for specifying their needs • Developing long term relationship with the clients and satisfying them is one of the crucial notches of the company. VynZ Research aims at gaining and retaining its clients in order to make long term customer relationship.
Global Lab On Chip (LOC) Market The global lab-on-a-chip market was valued at 5.18 billion in 2019 and is anticipated to grow at 11.25 billion by 2027, growing at a CAGR of 10.8% during the forecast period 2021-2027. A lab-on-a-chip (LOC) helps integrate laboratory functions through a single unified circuit. Lab-on-chips has been widely used in the field of diagnostics and is increasingly used in the application of microfluidic chip-based technology, such as chemical synthesis, medical diagnostics, and the study of complex cellular processes. In addition, LOC helps to provide rapid diagnostics, which are accessible, easy-to-operate options and gives efficient results in a snap of time. Increasing incidences of cancer, advancing fabrication technology, growing demand for miniature devices, research on biosensors and biomarkers, and economic feasibility are the leading factors driving the revenue growth of the lab-on-a-chip market. There is an increasing prevalence of swine flu, malaria virus, Ebola virus, and Zika Virus which will further drive the growth of the LOC market. Thus, these are the reasons for increasing the importance of the LOC market on a global scale.
Global Lab On Chip (LOC) Market The increasing popularity of personalized medicine, drug revelation, and life science research, adoption of biomarkers-based detection, and demand for high-speed diagnostic are important factors that fuel the growth of the global lab-on-chip market. LoC devices are portable and provide automated sample handling and reconfigurability. These devices offer rapid and on-time diagnosis results, thus they are used as point-of-care diagnosis Some applications of LoC technology in the biomedical field includes immunoassay LOC for bacteria detection, DNA chip, real-time PCR detection chip, and cellular analysis chip. This helps reduce energy consumption that helps provide rapid results. This helps provide rapid results and faster diagnostics. Moreover, LOC technology is very useful for biomarker-based detection that allows detecting oral cancer at an early stage and therefore could improve survival rate. These factors are strengthening the growth of the LOC market.
Global Lab On Chip (LOC) Market The multi-antigen COVID-19 biochip test, ImmuSAFE was launched by Sengenics. It uses the company’s patented KREX protein folding technology and is a lab-based biochip test. ImmuSAFE enables target identification of epitopes, titres, and Ig class/ sub-class of antibodies that are produced during COVID-19 infection. Agilent Technologies has unveiled three new microarrays to support pre-and postnatal research by cytogenetic laboratories. The key players in the LOC market include Becton, Dickinson and Company, Agilent Technologies, Inc., PerkinElmer, Inc., Danaher Corporation, Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics, Siemens Healthcare, Bio-Rad Laboratories, Abaxis Inc., Achira Labs, Advanced Liquid Logic and Advanced Microlabs.
For Sample Report :- https://www.vynzresearch.com/semiconductor-electronics/lab-on-chip-market/request-sample www.vynzresearch.com